Phagocytosis and killing of staphylococcus aureus by human neutrophils

Journal of Innate Immunity

Volumn 6, Issue 5, 2014, Pages 639-649

  Lu, Thea ^a   Porter, Adeline R ^a   Kennedy, Adam D ^a   Kobayashi, Scott D ^a   DeLeo, Frank R ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Neutrophils; Phagocytosis; Staphylococcus aureus

Indexed keywords

ADHERENT CELL; ARTICLE; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; CELL AGGREGATION; CELL SUSPENSION; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; FREEZE THAWING; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUTROPHIL; NEUTROPHIL GRANULE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PHAGOSOME; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ANTIBODY SPECIFICITY; BACTERIUM ADHERENCE; FEMALE; HOST RESISTANCE; INTERNALIZATION; NEW ZEALAND WHITE (RABBIT); CELL ADHESION; CELL CULTURE; CYTOTOXICITY; DRUG EFFECTS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; STAPHYLOCOCCAL INFECTIONS;

OPSONIN; BACTERIAL VACCINE; BACTERIUM ANTIBODY;

ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CELL ADHESION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; NEUTROPHILS; OPSONIN PROTEINS; PHAGOCYTOSIS; SERUM BACTERICIDAL TEST; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84906940464     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000360478     Document Type: Article

References (48)

1. Lee WL, Harrison RE, Grinstein S: Phagocytosis by neutrophils. Microbes Infect 2003; 5: 1299-1306.
2. Nordenfelt P, Tapper H: Phagosome dynamics during phagocytosis by neutrophils. J Leukoc Biol 2011; 90: 271-284.
3. Rigby K, DeLeo F: Neutrophils in innate host defense against Staphylococcus aureus infections. Semin Immunopathol 2012; 34: 237-259.
4. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M: Survey of infections due to Staphylococcus species: frequency of occurrenc e and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997 -1999. Clin Infect Dis 2001; 32:S114-S132.
5. DeLeo F, Chambers H: Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest 2009; 119: 2464-2474.
6. Wright AE, Douglas SR , John Burdon S: An experimental investigation of the role of the blood fluids in connection with phagocytosis. Rev Infect Dis 1989; 11: 827-834.
7. Verhoef J, Peterson P, Kim Y, Sabath LD, Quie PG: Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains. Immunology 1977; 33: 191-197.
8. Verbrugh HA, Van Dijk WC, Peters R, Van Der Tol ME, Peterson PK, Verhoef J: Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2. Immunology 1979; 36: 391-397.
9. Vandenbroucke Grauls CM, Thijssen HM, Verhoef J: Interaction between human polymorphonuclear leucocytes and Staphylococcus aureus in the presence and absence of opsonins. Immunology 19 84; 52: 427-435.
10. Kennedy A, Willment J, Dorward D, Williams D, Brown G, DeLeo F: Dectin-1 promotes fungicidal activity of human neutrophils. Eur J Immunol 2007; 37: 467-478.
11. Nauseef WM, Clark RA: Granulocytic Phagocytes. New York, Elsevier/Churchill Livingstone, 2010.
12. Fattom AI, Naso R: Staphylococcal vaccines: a realistic dream. Ann Med 1996; 28: 43-46.
13. Jansen KU, Girgenti DQ, Scully IL, Anderson AS: Vaccine review: ? Staphyloccocus aureus vaccines: problems and prospects'. Vaccine 2013; 31: 2723-2730.
14. Sp ellberg B, Daum R: Development of a vaccine against Staphylococcus aureus . Semin Immunopathol 2012; 34: 335-348.
15. Voyich J, Braughton K, Sturdevant D, Whitney A, Sad-Salim B, Porc ella S, Long RD, Dorward D, Gardner D, Kreiswirth B, Musser J, DeLeo F: Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005; 175: 3907-3919.
16. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F: Complete genome sequence of USA300, an epidemic c lone of communityacquired meticillin-resistant Staphylococcus aureus . Lancet 2006; 367: 731-739.
17. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asa no K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K: Genome and virulence determinants of high virulence communityacquired MRSA. Lancet 2002; 359: 1819-1827.
18. Holden MTG, Feil E J, Lindsay JA, Peacock SJ, Day NPJ, Enright MC, Foster TJ, Moore CE, Hurst L, Atkin R, Barron A, Bason N, Bentley SD, Chillingworth C, Chillingworth T, Churcher C, Clark L, Corton C, Cron i n A, Doggett J, Dowd L, Feltwell T, Hance Z, Harris B, Hauser H, Holroyd S, Jagels K, James KD, Lennard N, Line A, Mayes R, Moule S, Mungall K, Ormond D, Quail MA, Rabbinowitsch E, Ru t herford K, Sanders M, Sharp S, Simmonds M, Stevens K, Whitehead S, Barrell BG, Spratt BG, Parkhill J: Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and dr ug resistance. Proc Natl Acad Sci USA 2004; 101: 9786-9791.
19. Baba T, Bae T, Schneewind O, Takeuchi F, Hiramatsu K: Genome sequence of Staphylococcus aureus strain Newman and comparative anal ysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J Bacteriol 2008; 190: 300-310.
20. Gill SR, Fouts DE, Archer GL, Mongodin EF, DeBoy RT, Ravel J, Paulsen IT, Kolonay JF, Brinkac L, Beanan M, Dodson RJ, Daugherty SC, Madupu R, Angiuoli SV, Durkin AS, Haft DH, Vamathevan J, Khouri H, Utterback T, Lee C, Dimitrov G, Jiang L, Qin H, Weidman J, Tran K, Kang K, Hance IR, Nelson KE, Fraser CM: Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilmproducing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol 2005; 187: 2426-2438.
21. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki K, Nagai Y, Lian J, Ito T, Kanamori M, Matsumaru H, Maruyama A, Murakami H, Hosoyama A, Mizutani-Ui Y, Takahashi NK, Sawano T, Inoue R, Kaito C, Sekimizu K, Hirakawa H, Kuhara S, Goto S, Y abuzaki J, Kanehisa M, Yamashita A, Oshima K, Furuya K, Yoshino C, Shiba T, Hattori M, Ogasawara N, Hayashi H, Hiramatsu K: Whole genome sequencing of meticillin-resistant Staphylococcus aureus . Lancet 2001; 357: 1225-1240.
22. Kobayashi S, Voyich J, Buhl C, Stahl R, DeLeo F: Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: cell fate is r egulated at the level of gene expression. Proc Natl Acad Sci USA 2002; 99: 6901-6906.
23. DeLeo FR, Allen L-AH, Apicella M, Nauseef WM: NADPH oxidase activation and assembly during phagocytosis. J Immunol 1999; 163: 6732-6740.
24. Kobayashi S, Braughton K, Whitney A, Voyich J, Schwan T, Musser J, DeLeo F: Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci USA 2003; 1 00: 10948-10953.
25. DiMagno EP, Corle D, O'Brien JF, Masnyk IJ, Go VL, Aamodt R: Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum. Mayo Clin Proc 1989; 64: 1226-1234.
26. Decleva E, Menegazzi R, Busetto S, Patriarca P, Dri P: Common methodology is inadequate for studies on the microbicidal activity of neutrophils. J Leukoc Biol 2006; 79: 87-94.
27. Collins LV, Kristian SA, Weidenmaier C, Faigle M, van Kessel KPM, van Strijp JAG, Götz F, Neumeister B, Peschel A: Staphylococcus aureus strains lacking D-alanine modificat ions of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J Infect Dis 2002; 186: 214-219.
28. Wilsson A, Lundqvist H, Gustafsson M, Stendahl O: Killing of phagocytosed Staphylococcus aureus by human neutrophils requires intracellular free calcium. J Leukoc Biol 1996; 59: 902-907.
29. Hunt CL, Nauseef WM, Weiss JP: Effect of Dalanylation of (lipo)teichoic acids of Staphylococcus aureus on host secretory phospholipase A2 action before and after phagocytosis by human neutrophils. J Immunol 2006; 176: 4987-4994.
30. Verbrugh HA, Peters R, Peter son PK, Verhoef J: Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes. J Clin Pathol 1978; 31: 539-545.
31. Rogers DE, Tompsett R: The survival of staphylococci within human leukocytes. J Exp Med 1952; 95: 209-230.
32. Dugger KO, Galgiani JN: Neutrophil killing of single microorganisms as measured by a new method. Diagn Microbiol Infect Dis 1989; 12: 199-203.
33. Kobayashi S, Braughton K, Palazzolo Ballance A, Kennedy A, Sampaio E, Kristosturyan E, Whitney A, Sturdevant D, Dorward D, Holland S, Kreiswirth B, Musser J, DeLeo F: Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus . J Innate Immun 2010; 2: 560-575.
34. Malachowa N, Whitney AR, Kobayashi SD, Sturdevant DE, Kennedy AD, Braughton KR, Shabb DW, Diep BA, Chambers HF, Otto M, DeLeo FR: Global changes in Staphylococcus aureus gene expression in human blood. PLoS One 2011; 6:e18617.
35. Rogers DE, Melly MA: Observations on the immunology of pathogenic staphylococci. Yale J Biol Med 1962; 34: 560-581.
36. Cohn ZA,Morse SI: Interactions between rabbit polymorphonuclear leucocytes and staphylococci. J Exp Med. 1959; 110:419-443.
37. Leffell MS, Spitznagel JK: Intracellular and extracellular degranulation of human polymorphonuclear azurophil and specific granules induced by immune complexes. Infe ct Immun 1974; 10: 1241-1249.
38. Densen P, Mandel l GL: Gonococcal interactions with polymorphonuclear neutrophils: importance of the phagosome for bactericidal activity. J Clin Invest 1978; 62: 1161-1171.
39. Bellocchio S, Moretti S, Perruccio K, Fallarino F, Bozza S, Montagnoli C, Mosci P, Lipford GB, Pitzurra L, Romani L: TLRs govern neutrophil activity in aspergillosis. J Immunol 2004; 173: 7406-7415.
40. Kluytmans J, van Belkum A, Verbrugh H: Nasal carriage of Staphylococcus aureus : epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10: 505-520.
41. Lowy FD: Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-532.
42. Wood WB, Smith MR, Watson B: Studies on the mechanism of recovery in pneumococcal pneumonia: IV. The mechanism of phagocytosis in the absence of antib ody. J Exp Med 1946; 84: 387-402.
43. Ofek I, Goldhar J, Keisari Y, Sharon N: Nonopsonic phagocytosis of microorganisms. Annu Rev Microbiol 1995; 49: 239-276.
44. Jung D-J, An J-H, Kurokawa K, Jung Y-C, Kim M-J, Aoyagi Y, Matsushita M, Takahashi S, Lee H-S, Takahashi K, Lee B: Specific serum Ig recognizing staphylococcal wall teichoic acid induces complement-mediated opsonophagocytosis against Staphyl ococcus aureus . J Immunol 2012; 189: 4951-4959.
45. Theilacker C, Kropec A, Hammer F, Sava I, Wobser D, Sakinc T, Codée JDC, Hogendorf WFJ, van der Marel GA, Huebner J: P rotection against Staphylococcus aureus by antibody to the polyglycerolphosphate backbone of heterologous lipoteichoic acid. J Infect Dis 2012; 205: 1076-1085.
46. Ebert T, Smith S, Pancari G, Clark D , Hampton R, Secore S, Towne V, Fan H, Wang X-M, Wu X, Ernst R, Harvey BR, Finnefrock AC, Wang F, Tan C, Durr E, Cope L, Anderson A, An Z, McNeely T: A fully human monoclonal antibody to St aphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo. Hum Antibodies 2010; 19: 113-128.
47. Kobayashi SD, DeLeo FR: A MRSA-terious enemy among us: boosting MRSA vaccines. Nat Med 2011; 17: 168-169.
48. Gordon DL, Rice JL: Opsonin-dependent and independent surface phagocytosis of S. aureus proceeds independently of complement and complement receptors. Immunology 1988; 64: 709-714.